Kay B
Acta Anaesthesiol Belg. 1976;27 suppl:86-92.
Etomidate 0.2 mg/kg was used as an intravenous hypnotic to induce anesthesia in 198 children. If proved to be a safe and effective agent, with no appreciable side-effects on the cardiovascular or respiratory systems. The main problems in use were a high incidence (27%) of pain after injection, and a 10% incidence of significant myoclonia. In addition, 0.2 mg/kg was assessed as an inadequate induction dose of etomidate in unpremedicated children.
依托咪酯0.2毫克/千克被用作静脉催眠药，用于198名儿童的麻醉诱导。如果证明是一种安全有效的药物，对心血管或呼吸系统没有明显副作用。使用中的主要问题是注射后疼痛发生率高（27%），以及明显肌阵挛发生率为10%。此外，对于未用术前药的儿童，0.2毫克/千克的依托咪酯诱导剂量被评估为不足。
